Sale!

CACNA1S Gene Hypokalemic Periodic Paralysis Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CACNA1S gene hypokalemic periodic paralysis type 1 genetic test is a specialized diagnostic tool used to identify mutations in the CACNA1S gene, which are linked to hypokalemic periodic paralysis type 1 (HypoPP1). This condition is characterized by episodes of muscle weakness or paralysis, often triggered by factors such as rest after exercise, high carbohydrate meals, or stress, due to abnormally low levels of potassium in the blood (hypokalemia). The test is crucial for confirming the diagnosis, allowing for appropriate management and treatment strategies to be implemented.

Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves analyzing the patient’s DNA sample, typically collected through a blood draw, to search for specific genetic alterations in the CACNA1S gene known to cause the disorder. The presence of these mutations can confirm the diagnosis of HypoPP1, enabling affected individuals and their families to receive tailored advice on managing the condition, including preventive measures for avoiding triggers and potential treatments to alleviate symptoms.

The cost of the CACNA1S gene hypokalemic periodic paralysis type 1 genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the CACNA1S gene and provide individuals with reliable results. By opting for this test, patients gain crucial insights into their condition, empowering them with the knowledge needed to manage their health effectively.

Description

CACNA1S Gene Hypokalemic periodic paralysis type 1 Genetic Test

Test Name: CACNA1S Gene Hypokalemic periodic paralysis type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CACNA1S Gene Hypokalemic periodic paralysis type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1S Gene Hypokalemic periodic paralysis type 1.

Test Details: The CACNA1S gene is responsible for producing a protein called the L-type calcium channel alpha-1 subunit. Mutations in this gene can lead to a condition called Hypokalemic periodic paralysis type 1. Hypokalemic periodic paralysis is a rare genetic disorder characterized by episodes of muscle weakness or paralysis that are typically triggered by a decrease in blood potassium levels (hypokalemia). These episodes can last from hours to days and may be accompanied by other symptoms such as muscle pain, stiffness, or cramps.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes simultaneously. In the case of Hypokalemic periodic paralysis type 1, NGS genetic testing can be used to identify mutations in the CACNA1S gene that may be causing the condition. By identifying the specific mutation in the CACNA1S gene, NGS genetic testing can help confirm a diagnosis of Hypokalemic periodic paralysis type 1 and provide valuable information for treatment and management of the condition. It can also be used for genetic counseling and to determine the risk of passing the condition on to future generations.

It is important to note that NGS genetic testing should be ordered and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate guidance and support throughout the testing process.

Test Name	CACNA1S Gene Hypokalemic periodic paralysis type 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CACNA1S Gene Hypokalemic periodic paralysis type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1S Gene Hypokalemic periodic paralysis type 1
Test Details	The CACNA1S gene is responsible for producing a protein called the L-type calcium channel alpha-1 subunit. Mutations in this gene can lead to a condition called Hypokalemic periodic paralysis type 1. Hypokalemic periodic paralysis is a rare genetic disorder characterized by episodes of muscle weakness or paralysis that are typically triggered by a decrease in blood potassium levels (hypokalemia). These episodes can last from hours to days and may be accompanied by other symptoms such as muscle pain, stiffness, or cramps. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes simultaneously. In the case of Hypokalemic periodic paralysis type 1, NGS genetic testing can be used to identify mutations in the CACNA1S gene that may be causing the condition. By identifying the specific mutation in the CACNA1S gene, NGS genetic testing can help confirm a diagnosis of Hypokalemic periodic paralysis type 1 and provide valuable information for treatment and management of the condition. It can also be used for genetic counseling and to determine the risk of passing the condition on to future generations. It is important to note that NGS genetic testing should be ordered and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate guidance and support throughout the testing process.